MAPT and Alzheimer disease: This is especially challenging when it comes to PSP/CBD as most research relating to tau is done in AD models, which contain other toxic proteinopathies and distinct tau isoforms than that of PSP/CBD, thus, there is a research gap in tau in the context of PSP/CBD.